Filing Details

Accession Number:
0001179110-12-003335
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-02-23 16:02:31
Reporting Period:
2012-02-21
Filing Date:
2012-02-23
Accepted Time:
2012-02-23 16:02:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1113481 Medicines Co MDCO Pharmaceutical Preparations (2834) 043324394
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1277478 Glenn Sblendorio 8 Sylvan Way
Parsippany NJ 07054
Executive Vp & Cfo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-02-21 1,505 $20.94 65,097 No 4 S Direct
Common Stock Disposition 2012-02-21 833 $20.94 64,264 No 4 S Direct
Common Stock Disposition 2012-02-21 1,781 $20.94 62,483 No 4 S Direct
Common Stock Acquisiton 2012-02-21 625 $7.31 63,108 No 4 M Direct
Common Stock Disposition 2012-02-21 625 $21.03 62,483 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option(right to buy) Disposition 2012-02-21 625 $7.31 625 $7.31
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
16,250 2020-02-19 No 4 M Direct
Footnotes
  1. Represents the number of shares sold to cover the tax expense associated with the vesting of restricted shares held by Mr. Sblendorio pursuant to his Restricted Stock Agreements with the Company.
  2. As of 2/21/2012, the original grant (30,000 shares granted on 2/19/2010) was vested with respect to 15,000 of the shares covered thereby and the remaining 15,000 shares covered by this option vest in equal monthly installments ending on 2/19/2014. After the exercise of the options reported hereby, as of 2/21/2012, 1,250 of the shares covered by the option were vested but not exercised.
  3. The common stock sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 program adopted by Mr. Sblendorio on February 18, 2011.